These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37805620)

  • 41. Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement.
    Coropciuc R; Moreno-Rabié C; De Vos W; Van de Casteele E; Marks L; Lenaerts V; Coppejans E; Lenssen O; Coopman R; Walschap J; Nadjmi N; Jacobs R; Politis C; Van den Wyngaert T
    Acta Chir Belg; 2024 Feb; 124(1):1-11. PubMed ID: 38059301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw.
    Tadokoro Y; Hasegawa T; Takeda D; Murakami A; Yatagai N; Arimoro S; Iwata E; Saito I; Kusumoto J; Akashi M
    Head Neck; 2024 Feb; 46(2):282-290. PubMed ID: 37962011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical status of established MRONJ in oncology patients continuing bone-modifying agents.
    Miles E; Arya R; Sproat C; Patel V
    Br Dent J; 2024 May; 236(9):683-687. PubMed ID: 38730156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK; Ogle O
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
    Jackson GH; Morgan GJ; Davies FE; Wu P; Gregory WM; Bell SE; Szubert AJ; Navarro Coy N; Drayson MT; Owen RG; Feyler S; Ashcroft AJ; Ross FM; Byrne J; Roddie H; Rudin C; Boyd KD; Osborne WL; Cook G; Child JA
    Br J Haematol; 2014 Jul; 166(1):109-17. PubMed ID: 24673708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
    Massaad J; Magremanne M
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e743-e748. PubMed ID: 34922047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience.
    Chen S; Ren H; He Y; An J; Zhang Y
    J Oral Maxillofac Surg; 2021 Dec; 79(12):2472-2481. PubMed ID: 34481810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical students' knowledge of medication related osteonecrosis of the jaw.
    Franchi S; Brucoli M; Boffano P; Dosio C; Benech A
    J Stomatol Oral Maxillofac Surg; 2020 Sep; 121(4):344-346. PubMed ID: 31672685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
    Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
    Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Somay E
    Osteoporos Int; 2023 Oct; 34(10):1811-1812. PubMed ID: 37418153
    [No Abstract]   [Full Text] [Related]  

  • 53. Multiple myeloma masquerading as mandibular medication-related osteonecrosis of the jaw: a case report.
    Danskin Y; Alhajji D; Singh A; Rota A; Huryn JM; Estilo CL
    Aust Dent J; 2022 Mar; 67(1):94-99. PubMed ID: 34706097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.
    Nicolatou-Galitis O; Schiødt M; Mendes RA; Ripamonti C; Hope S; Drudge-Coates L; Niepel D; Van den Wyngaert T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Feb; 127(2):117-135. PubMed ID: 30393090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pembrolizumab related osteonecrosis of the jaw.
    Patel V; Carey B
    Br J Oral Maxillofac Surg; 2023 Dec; 61(10):704-706. PubMed ID: 37957097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, Incidence Rate, and Risk Factors of Medication-Related Osteonecrosis of the Jaw in Patients With Osteoporosis and Cancer: A Nationwide Population-Based Study in Japan.
    Ishimaru M; Ono S; Morita K; Matsui H; Hagiwara Y; Yasunaga H
    J Oral Maxillofac Surg; 2022 Apr; 80(4):714-727. PubMed ID: 35033505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication-related osteonecrosis of the jaw: A literature review and update.
    Kuroshima S; Al-Omari FA; Sasaki M; Sawase T
    Genesis; 2022 Sep; 60(8-9):e23500. PubMed ID: 36106755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study.
    Kwoen MJ; Park JH; Kim KS; Lee JR; Kim JW; Lee H; Lee HJ
    J Periodontol; 2023 Jan; 94(1):98-107. PubMed ID: 35856336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.